As a result of the Ukraine-Russia War and COVID-19 epidemic, the global Cyclodextrin market size is estimated to be worth US$ 215.8 million in 2021 and is forecast to a readjusted size of US$ 328.2 million by 2028 with a CAGR of 6.1% during the forecast period 2022-2028.
Asia-Pacific is the largest market with about 50% market share. Europe is follower, accounting for about 27% market share.
The key players are Wacker, Ensuiko Sugar Refining, Nihon Shokuhin Kako, Roquette, Ashland, Shandong Xinda, Yunan Yongguang, Qufu Tianli, Zibo Qianhui, Jiangsu Fengyuan, Mengzhou Huaxing, Mengzhou Hongji etc. Top 3 companies occupied about 57% market share.
The global beta-cyclodextrin in Pharma market size is estimated to be worth USD 36 million in 2022 and is forecast to a readjusted size of USD 53 million by 2028 with a CAGR of 6.7% during the forecast period 2022-2028.
Global key manufacturers of beta-cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.